Saliva PCR in Pregnant Women with COVID-19

计划入组 37 人 · 首次发布于 2024 年 12 月 16 日

A Study of COVID-19 Patients Receiving Treatment With Nirmatrelvir; Ritonavir in the Kingdom of Saudi Arabia

计划入组 250 人 · 首次发布于 2023 年 8 月 29 日

A Study to Learn About the Use of Paxlovid in Patients With COVID-19 in the Kingdom of Bahrain.

计划入组 3,011 人 · 首次发布于 2024 年 3 月 4 日

Nirmatrelvir(Paxlovid)

C₂₃H₃₂F₃N₅O₄

Deuterated-Nirmatrelvir

PF-07321332 + ritonavir

COVID-19 Antivirals Nirmatrelvir/Ritonavir and Molnupiravir Show Promise in Reducing Cardiovascular Risks

Paxlovid Reduces Risk of Long COVID and Post-Acute Hospitalization or Death in High-Risk Patients

Extended Paxlovid Treatment Reduces Viral Rebound in Immunocompromised COVID-19 Patients